Previous 10 | Next 10 |
2023-11-14 16:00:00 ET Summary Avadel Pharmaceuticals reported strong Q3 earnings for Lumryz, exceeding consensus estimates and demonstrating successful market launch. Avadel's strategic market positioning and focus on high-volume prescribers contribute to its strong market positi...
2023-11-12 03:02:52 ET Summary Lumryz's once-at-bedtime dosing shows clinical and market promise, with early revenue and patient adoption. Avadel faces high operating expenses and cash burn, raising concerns despite a solid liquidity position. Generic competition and supply ch...
2023-11-08 13:48:10 ET Avadel Pharmaceuticals PLC (AVDL) Q3 2023 Earnings Conference Call November 08, 2023, 08:30 ET Company Participants Austin Murtagh - Stern Investor Relations Gregory Divis - CEO & Director Richard Kim - Chief Commercial Officer Jenn...
2023-11-08 07:15:10 ET More on Avadel Pharmaceuticals Avadel Pharmaceuticals: A Resilient Buy; A Comprehensive Assessment Of Potential Prospects Seeking Alpha’s Quant Rating on Avadel Pharmaceuticals Historical earnings data for Avadel Pharmaceuticals ...
-- $7.0 million in third quarter LUMRYZ™ net revenue from U.S. commercial launch -- -- Generated robust demand for LUMRYZ with greater than 1,000 patients enrolled in RYZUP TM and more than 400 patients initiating therapy as of September 30 -- -- LUMRYZ to be ...
Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...
Avadel Pharmaceuticals plc (AVDL) is expected to report $-0.35 for Q3 2023
2023-11-07 12:30:52 ET More on Avadel Pharmaceuticals Avadel Pharmaceuticals: A Resilient Buy; A Comprehensive Assessment Of Potential Prospects Avadel Pharmaceuticals plc (AVDL) Q2 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Avadel Pharmaceu...
2023-10-31 17:24:37 ET Gainers: Freshworks (FRSH) +5% . Verve Therapeutics ( VERV ) +3% . Expensify ( EXFY ) +3% . REGENXBIO ( RGNX ) +3% . ACI Worldwide ( ACIW ) +3% . Losers: Big 5 Sporting Goods ( BGFV ) -11% . ...
DUBLIN, Ireland, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it will host a conference call and live webcast at 8:30 a.m. ET on Wednesday, November 8, 2023, to p...
News, Short Squeeze, Breakout and More Instantly...
Avadel Pharmaceuticals plc Company Name:
AVDL Stock Symbol:
NASDAQ Market:
Avadel Pharmaceuticals plc Website:
DUBLIN, June 27, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it is set to join the broad-market Russell 3000 ® Index at the conclusion of the 2024 Russell US Ind...
2024-05-29 06:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
– 11 accepted abstracts, including new data reiterating satisfaction, preference and clinical benefit of LUMRYZ – – Presentations highlight Avadel’s continued commitment to address gaps in narcolepsy care – DUBLIN, May 22, 2024 (GLOBE NEWSWIRE) -...